Daridorexant for adults with insomnia
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study follows adults with insomnia who are prescribed a new sleep medication called daridorexant. It aims to see how well the medication works in a real-world setting, and to monitor its safety and effects on sleep.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You should have trouble falling asleep, staying asleep, or waking up too early at least 3 nights per week, and it should affect your daytime functioning.
- Your insomnia should be moderate or more severe, as measured by a standard questionnaire.
- You need to be able to stay in bed for at least 7 hours each night.
- You should not have severe depression or anxiety, and you must not have thoughts of suicide.
- You should not have tried two or more sleep medications without improvement.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.
This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.
This study tests a sleep medication called daridorexant to see if it helps smokers sleep better and feel more alert during the day, which might make it easier to cut back on smoking. You'll take the medication for 3 weeks and track your sleep and smoking at home.
This study tests combining a CPAP machine with a sleep medication called daridorexant to treat people who have both sleep apnea and insomnia. It aims to see if this combination therapy is safe and effective for people who are just starting treatment.
This study tests a sleep treatment given under anesthesia to help people with severe, long-lasting insomnia that hasn't improved with other treatments. It looks at whether this approach is safe and effective for improving sleep and daytime function.
This trial tests three different treatments for insomnia that started or got worse during the menopausal transition. One is a digital therapy app, and the others are two different medications. The goal is to see which works best for women aged 40–62 who are in the early stages of menopause.
Hear when a new Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.